key: cord-0959133-t7cyg8ji
authors: Haas, Cyrus M.; Francino-Urdaniz, Irene M.; Steiner, Paul J.; Whitehead, Timothy A.
title: Identification of SARS-CoV-2 S RBD escape mutants using yeast screening and deep mutational scanning
date: 2021-09-22
journal: STAR Protoc
DOI: 10.1016/j.xpro.2021.100869
sha: 5987f22e342bb52fe328b5ce11f66dfe671d3c7a
doc_id: 959133
cord_uid: t7cyg8ji

Here we describe a protocol to identify escape mutants on the SARS-CoV-2 Spike (S) receptor binding domain (RBD) using a yeast screen combined with deep mutational scanning. Over 90% of all potential single S RBD escape mutants can be identified for monoclonal antibodies that directly compete with angiotensin-converting enzyme 2 for binding. Six to ten antibodies can be assessed in parallel. This approach has been shown to determine escape mutants that are consistent with more laborious SARS-CoV-2 pseudo neutralization assays.

For this step, the plasmid containing yeast display backbone (pJS697) and a plasmid containing the S RBD insert (see Table 1 for variations) are digested. All yeast display plasmids are freely available via AddGene as E. coli glycerol cell stocks.

Timing: 1 day Day 1: Plasmid Preparation 2. Digest backbone (pJS697; two BsaI restriction sites) and RBD-encoding (pJS699; two NotI restriction sites) plasmids. The pIFU-series plasmids follow the same procedure as pJS699.

a. Set up digestion reactions as follows:

pJS697 (pJS697 for library) n/a 1 µg (5 µg)

10X CutSmart Buffer n/a 5 µL BsaI-HFv2 n/a 1 µL Nuclease-free water n/a to 50 µL Total n/a 50 µL Note: Digestions are set up following NEB recommendations (NEB cloner).

pJS699 (or pJS699_L1, pJS699_L2) n/a 1 µg (5 µg)

i. Purify the backbone from the pJS697 digestion using a Monarch PCR & DNA purification kit. The digestion will result in two linear DNA pieces: the insert between BsaI sites is 26bp and the backbone is 6042bp in length. DNA smaller than 45bp will not stick to the column (Monarch PCR & DNA Cleanup kit) so the eluate will only contain the backbone. Thus, gel electrophoresis and extraction are not necessary with the pJS697 digestion.

ii.

Purify the linear insert from the pJS699 digestion containing S RBD by gel electrophoresis and gel extraction. The digestion will result in two linear DNA pieces: one at 832 bp and the other at 2692 bp. Excise the 832 bp fragment and purify using a Monarch Gel Extraction kit (NEB).

d. Quantify the linear DNA products by A260 using a UV-Vis plate reader or nanodrop spectrophotometer. Typical yields for the digestion of 1 µg plasmid DNA are 600 ng (30 ng/µL) for backbone and 100 ng (5 ng/µL) for the gene encoding S RBD.

Note: Linearized plasmids can be stored frozen at -20℃ for at least 3 weeks.

Co-transformation of S RBD wild type into S. cerevisiae EBY100

Here, the yeast display backbone from the digest reaction (pJS697) is recombined with the insert containing the S RBD by co-transformation into chemically competent S. cerevisiae EBY100 (ATCC MYA-4941) following Medina-Cucurella and Whitehead (2018) . This step along with transformations for the S RBD libraries can be prepared in parallel.

Day 1: Plasmid Co-transformation for Linear DNA of Yeast Display Backbone 3. Co-transform linear DNA corresponding to the yeast display backbone and S RBD insert into chemically competent S. cerevisiae EBY100 (MYA-4941 TM ) ( Figure 1A ).

a. Boil 10 µL salmon sperm DNA 10min at 97℃ using a Thermal Cycler.

b. Thaw chemically competent EBY100. Thawing can be performed either at 20-25°C or on ice.

c. In a 1.5mL microcentrifuge tube add in order: e. Add DNA in a 3:1 insert to backbone molar ratio to give a final concentration of 1.5 µg DNA (1.06 µg vector and 440 ng insert). Alternatively, to obtain more transformants, the amount of DNA transformed can increase up to 5 µg total without increasing the amount of other reagents.

f. Incubate 30min at 30℃ in a static incubator (preferred) or Thermal Cycler.

g. Incubate 20min at 42℃ in a water bath (preferred) or Thermal Cycler.

h. Spin down 30s at 16000 × g using a microcentrifuge. Remove supernatant.

i. Resuspend in 1mL SDCAA (recipe -make SDCAA + without antibiotics) and incubate for 5 min at 20-25°C.

j. Make 6 serial dilutions and plate 10 µL of each in an SDCAA agar plate to calculate transformation efficiency. Incubate 2-3 days at 30℃ . Obtaining near-complete (>99.9%) coverage of the libraries requires >1.2×10 5 transformants for each library (Steiner, Baumer and Whitehead, 2020) . The first tile (333-437) contains 1120 mutations and the second tile encodes 1260 mutations. The number of transformants obtained can be increased by scaling up the transformation, using more DNA, or using freshly prepared competent cells before freezing.

k. Transfer remaining culture into 100mL SDCAA + (recipe) in a 500 ml flask. Incubate at 30℃ and 300rpm in the incubator shaker until saturation. This typically takes 48 hours. ii.

Remove the supernatant and resuspend the cell pellet in yeast storage buffer (recipe) at OD600=10. Stocks can be stored for over a year at -80 o C.

Confirm that neutralizing antibodies selected bind and inhibit the yeast displayed glycosylated WT RBD A recommended though not essential step is to confirm that your neutralizing antibody binds to displayed RBD and can competitively inhibit binding of surface-displayed S RBD to soluble ACE2. Here, yeast cells are grown from frozen stocks and induced for 16-20 hours. For labeling, our lab prepares chemically biotinylated soluble ACE2-Fc produced by the Institute of Protein Design (Walls et al., 2020) . However, biotinylated soluble ACE2 is now commercially available (e.g. R&D Systems Cat# BT933-020). We have not validated the use of other sources of ACE2 in this protocol. We biotinylate ACE2-Fc with NHS-Biotin following the vendor's protocol (User guide: EZ-link NHS Biotin) using a biotin to protein molar ratio from 20:1 to 80:1.

Day 1: Cell Induction 5. Thaw a 1mL stock of yeast cells harboring the S RBD display plasmid.

6. Pellet the cells by centrifuging 1 min at 16000 x g using a microcentrifuge, remove supernatant, and resuspend in 1 mL SDCAA + (recipe). Transfer culture to a 14 mL culture tube (VWR Cat#10127-334).

7. Incubate at least 4h at 30℃ and 300rpm in an incubator shaker. The cell concentration should double, but the culture should not be saturated. It is convenient to set this culture up in the morning so that cytometer screening can be performed during daytime hours on the following day.

8. Measure the culture OD600 with a spectrophotometer. Centrifuge the cells 1 min at 16000 x g in a microcentrifuge and resuspend to OD600=1 in SGCAA + (recipe).

9. Transfer 1 mL of the culture to a new 14 mL culture tube and incubate for 22 h at 22℃ and 300 rpm in an incubator shaker.

Day 2: Test cells for (i.) surface display of S RBD; (ii.) ability to bind biotinylated ACE2; (iii.) ability to bind antibody of interest; and (iv.) for antibody ability to competitively inhibit ACE2.

10. Transfer the culture to a 1.5 mL microcentrifuge tube and centrifuge for 1 min at 16000 x g using a microcentrifuge.

11. Measure the culture OD600 and resuspend the cells in ice cold PBSF to an OD600=2. From this point, keep the cells on ice at all times except when otherwise specified. We typically perform a 10-fold dilution of the culture with PBSF to determine the OD600. The yeast culture does not usually grow during the 16-20 hour induction with common resuspension volumes under 1 mL.

On the same day, prepare PBSF (recipe) and keep on ice for the duration of the experiments. PBSF needs to be ice cold whenever added to cells.

12. Add 5 µL cells with 45 µL of PBSF ('unlabeled' cells) in a 1.5mL microcentrifuge tube. Incubate 30 min at RT (20-25°C).

13. Centrifuge 1 min at 16000 x g using a microcentrifuge and resuspend the cells in 100µL ice cold PBSF. Screen 25,000 unlabeled cells. These unlabeled cells are used to set a FSC-A/FITC + gate to collect 0% of the events. Refer to FACS for more detail on setting the gates ( Figure  2B ). J o u r n a l P r e -p r o o f For example: In tube 1, if your biotinylated ACE2 concentration was 1 µM, you would add 5 μL of cells, 41.2 μL PBSF, and 3.8 μL antibody.

Optional: Yeast surface titration can be performed following Chao et al. (2006) to determine the effective dissociation constant. The observed dissociation constants of different ACE2-Fc preparations range from 200 pM to 2 nM.

18. Centrifuge 1 min at 16000 x g using a microcentrifuge. Wash twice with 200 µL PBSF and remove supernatant.

19. Resuspend each cell pellet in 50 µL fluorescent labelling mix (recipe). The set up for each tube is shown in the following 

The cell pellet can be stored on ice until ready to screen. We do not recommend storing on ice for longer than 1h as fluorophores can dissociate, resulting in a lower signal.

22. Resuspend the cells in 100 µL PBSF. Screen 25,000 cells.

The results of this experiment tell us the likelihood of success for the escape mutant protocol. First, the ACE2 binding population signal must be significantly higher and independent from the non-displaying population on the PE + /FITC + ( Figure 1C ). Refer to Troubleshooting 2 to help improve signal. Second, if no PE signal increase is observed for the biotinylated ACE2 labeling (tube 1) and antibody labeling (tube 2) yeast cells, then the antibody does not bind to the aglycosylated RBD and cannot be used with this method (see Figure 1B for expected results). Third, the competitive inhibition reaction should result in minimal PE signal corresponding to ACE2 binding (tube 3). If a PE signal increase is observed, the antibody does not compete with ACE2 for binding to the RBD and thus, cannot be used with this method ( Figure 1D ).

The fluorescent channel associated with the binding event will be dependent on the choice of secondary label. We use phycoerythrin (PE) as a fluorophore as it is compatible with anti-cmyc FITC and utilizes a 488 nm laser. Other fluorophores can be used.

23. If the antibody binds to RBD and blocks ACE2 binding, co-transform the libraries into yeast and make yeast stocks:

a. Centrifuge the cell culture 3 min at 3200 x g.

b. Remove the supernatant and resuspend the cell pellet in yeast storage buffer (recipe) at OD600=10. Stocks can be stored for over a year at -80 o C.

Prepare operating system for running software with its dependencies Autoclave 20 min at 121°C and 0.5 bar gauge.

Difico yeast nitrogen base 6.7 g/L 3.35 g Bacto casamino acids 5 g/L 2.5 g Dextrose 20% w/v 10 g ddH2O n/a to 50 mL

Filter sterilize using a 0.22µm filter.

Cool autoclaved mixture (Solution A) with stirring until below 50℃ , add filter-sterilized solution (Solution B), mix well, and pour plates. Plates can be stored for up to 6 months at 4℃ .

bovine serum albumin frac V 1 g/L 100 mg PBS n/a 100 mL

Filter sterilize using a 0.22µm filter and store at 4℃ for no longer than 3 days. Make on same day of use and store on ice, protected from light. We recommend making a master mix, adding an extra 10% for each reaction.

Step-by-step method details

Timing: 26 hours S RBD is expressed in yeast from a galactose-inducible promoter. The first step is to expand cells from a frozen stock and then induce S RBD display by growth on galactose.

1. Thaw 1mL stock of yeast cells harboring the S RBD display plasmid of the desired library for identifying escape mutants and WT for controls (Confirm that antibodies selected bind and inhibit the displayed WT RBD). It is convenient to start this growth step in the morning so that cytometer screening can be performed during daytime hours on the following day.

2. Pellet the cells by centrifuging 1 min at 16000 x g using a microcentrifuge, remove supernatant, and resuspend in SDCAA + (recipe).

3. Transfer culture to a 14 mL culture tube for volumes lower than 1.5 mL (VWR Cat#10127-334) or a 250 mL shaker flask for large volumes (Fisher Cat# 10040F). Incubate cells at 30℃ and 300rpm for 4-6 hours.

Note: Do not grow cultures of more than 1.5 mL volume in 14 mL tubes, as they are insufficiently aerated for optimal display. 4. Measure the culture OD600 with a spectrophotometer. If 1.2 < OD600 < 5, harvest the cells by centrifugation for 1 min at 16000 x g in a microcentrifuge and resuspend to OD600=1 in SGCAA + (recipe).

5. Transfer the appropriate amount of the culture to a new 14mL culture tube or a 250mL shaker flask as necessary and incubate 22h at 22℃ and 300rpm in an incubator shaker. As previously stated, we recommend using 14 mL culture tubes for the volumes lower than 1.5 mL and 250 mL shaker flasks for larger volumes.

Timing: 4 hours J o u r n a l P r e -p r o o f Yeast cells displaying nearly all possible single point mutants on surface exposed positions of S RBD are pre-incubated with a neutralizing antibody before co-incubation with biotinylated ACE2. These cells are then labeled with secondary fluorophores to detect S RBD expression and ACE2 binding. Fluorescence activated cell sorting (FACS) is used to isolate the population of cells still able to bind ACE2.

The binding reactions cannot be stored to sort another day. If multiple antibodies are being tested, we recommend splitting the samples into multiple days.

6. Transfer the culture to a 1.5 mL microcentrifuge tube for low volumes or a 15 mL conical tube for larger volumes and centrifuge for 1 min at 16000 x g using a centrifuge.

7. Measure the culture OD600 and resuspend the cells in ice cold PBSF to an OD600=2 for the controls and to an OD600=10 for sorting. We typically perform a 10-fold dilution of culture to determine the OD600. The yeast culture will not necessarily increase in OD600 during this 16-24 hour induction.

Note: Keep this suspension on ice during the whole procedure except when otherwise specified.

Incubate 30 min at 20-25°C.

9. Centrifuge 1 min at 16000 x g using a microcentrifuge and resuspend the cells in 100µL ice cold PBSF. Screen 25,000 unlabeled cells and set the FSC-A/FITC + gate as in Figure 2B .

10. Label 5 µL cells with 44 µL of PBSF and 1 µL of anti-c-myc FITC in a 1.5mL microcentrifuge tube. Mix by pipetting up and down several times. Incubate the cells on ice for 10 min protected from light.

11. Centrifuge the cells 1 min at 16000 x g using a microcentrifuge. Wash twice with 200 µL ice cold PBSF and remove supernatant. Cell pellets can be stored on ice until ready to screen.

12. Resuspend the cells in 100µL ice cold PBSF and screen 25,000 cells. If the yeast does not display the S RBD, do not prepare the binding reactions and refer to Troubleshooting 1.

Check Unlabeled Cells, ACE2 Binding, and Competitive Inhibition. These are the recommended controls for WT and each library sorted. The unlabeled cells will be used to set the correct gates on FACS for each different library sorted. The ACE2 binding is the positive control and the competitive inhibition the negative control.

13. Set up three separate labeling reactions in three different 1.5 mL microcentrifuge tubes using the cells at OD600=2. Incubate 30 min at 20-25°C. Ensure that the biotin:protein molar ratio has been adjusted before starting the escape mutant identification, else, refer to 'Confirm that antibodies selected bind and inhibit the displayed WT RBD'.

Library Cells 5µL 5µL -

To 50µL total volume To 50µL total volume To 50µL total volume

Incubate for 30 minutes at 20-25°C. c. Incubate 10 min on ice and protect from light.

d. Centrifuge 1 min at 16000 x g using a microcentrifuge. Wash twice with 200 µL PBSF and remove supernatant. The cell pellet can be stored on ice until ready to screen. We do not recommend storing on ice for longer than 1h as fluorophores might dissociate, resulting in a lower signal.

e. Resuspend the cells in 100 µL PBSF and screen 25,000 cells. (Figure 2A) 14. In a 1.5mL microcentrifuge tube add 150 µL of cells, PBSF, and 10 µg/mL antibody to a final volume of 400 µL. Incubate 30 min at 20-25°C. Then, add biotinylated ACE2 to a final concentration of 75nM. Again, incubate 30 min at 20-25°C.

If multiple samples are sorted, it is better to incubate pellets on ice before the next step. Fluorescent label right before sorting to ensure maximum fluorescence. To minimize binding loss, stagger the binding reactions to minimize the storage time so that when the reaction is completed, the sample can be sorted.

a. Centrifuge 1 min at 16000 x g using a microcentrifuge. Wash twice with 1 mL PBSF and remove supernatant. Cell pellets can be stored on ice for ~4 h without significant binding loss if all the supernatant is removed.

b. Resuspend each cell pellet with 200 µL fluorescent labelling mix (recipe). Keep the fluorescent labelling mix on ice and always protected from light.

Better results are obtained if the cells are fluorescently labelled right before sorting.

c. Incubate 10 min on ice and protect from light.

d. Centrifuge 1 min at 16000 x g using a microcentrifuge. Wash twice with 1 mL PBSF and remove supernatant. Cell pellets can be stored covered and on ice until ready to screen.

Optional: While sorting, the fluorescence signal might decrease over time. If the decrease is significant, divide the sample into two 500 µL samples and spin down again, remove supernatant and spin down to make sure no liquid is left in the sample. Store each pellet on ice until ready to use.

Timing: approx. 40 min per sorted sample Cells are sorted by FACS using four separate gates (Figure 2) . We first set an SSC/FSC gate for isolation of yeast cells. The second gate set is on FSC-H/FSC-A to discriminate single yeast cells from budding cells and/or aggregates. The third gate is an FSC-A/FITC + gate that selects the cells displaying the RBD on their surface and excludes cells not displaying RBD. The fourth gate is a square gate collecting the top 2% by a PE + /FITC + ( Figure 2B ). The first three gates are set using unlabeled cells as described below. The collection PE + /FITC + gate is adjusted for each sorted sample to collect the cells giving the top 2% PE fluorescence signal. We set a 2% limit for collecting the population of the PE fluorescence signal for two reasons. First, collecting the entire population would require collecting considerably more cells to obtain the same quality in results since different PE signal increases correlate with varying affinity. In addition, collecting the top 2% allows us to set a false discovery rate (FDR) given that cells with higher signal are likely to contain escape mutants. Figure  2B . Note: Using our Sony SH-800 cytometer, it typically takes 40min to collect 200,000 cells in the control and sample populations. This time results from a sorting rate of 5-10,000 cells per sec and maintaining a 70% sorting efficiency.

Note: To avoid complexity bottlenecks, it is important that the number of collected cells is at least 150X the theoretical library size. For a library with NNK mutations on 56 and 63 mutations for library 1 and 2 respectively, 168,000 cells for library 1 and 189,000 cells for library 2 must be collected. Results are improved with more collected cells.

Cells are recovered and yeast stocks are prepared.

19. Centrifuge collection tube containing the collected cells 5 min at 3200 x g using a centrifuge. Collected cells are smaller than typical yeast bulk population, and therefore a longer centrifugation time of 5 min is required.

20. Remove approx. 80% of the supernatant and resuspend in 1.5mL SDCAA + at 30℃ for 16-20 hours at 300rpm in an incubator shaker in the 14mL culture tubes.

Note: 14mL culture tubes cannot hold more than 1.5mL. Larger volumes are not well aerated. To use a larger resuspension volume, grow the culture in a 25 mL shaker flask.

21. Passage cells into 3 culture tubes using 1.5mL SDCAA + on each. Incubate at 30℃ and 300rpm for 16-24 hours.

22. Prepare 1mL cell stocks at OD600=4 in yeast storage buffer at -80℃ .

a. Centrifuge the cell culture 2 min at 3200 x g.

b. Remove the supernatant and resuspend the cell pellet in yeast storage buffer (recipe) at OD600=4. Stocks can be stored for over a year at -80 o C. In total, at least 1 mL cell stock at OD600=4 is needed for deep sequencing preparation.

After 16-24 hours of growth, plasmid DNA from this population is isolated and prepared for deep sequencing. Plasmid DNA from cells is extracted and amplicons prepared for Illumina sequencing (Figure 3) . The protocol used is adapted from Method B detailed in Kowalsky et al. (2015) . c. Add 5μl Zymolyase (5U/μl).

d. Incubate in a 37˚℃ incubator for 4h on an end-to-end mixer or incubate at 37℃ with mixing by pipetting up and down (ten times) every hour.

e. Perform 1 freeze-thaw cycle using a dry ice/EtOH bath followed by a 42℃ incubation for 10 min. Alternatively, freeze at -80℃ for 20 min and thaw at 42℃ in a temperature bath.

f. Add 200 μL Solution 2 from Zymo Yeast Plasmid Miniprep kit, mix end-over-end and let sit for 5 min. The solution will be transparent.

g. Add 400 µL Solution 3 from Zymo Yeast Plasmid Miniprep kit mix end-over-end centrifuge 5 min at 16000 x g. The solution will turn yellow, and precipitate will form.

h. Transfer supernatant to a NEB miniprep column.

The NEB miniprep column has a higher DNA binding capacity (15 μg) compared to the Zymo miniprep columns (5 μg). The rationale for using NEB miniprep columns is that lysed cells contain large amounts of sheared yeast genomic DNA in addition to the desired plasmid DNA.

i. Centrifuge 1 min at 16000 x g using a microcentrifuge.

j. Add 700 μl Wash 1 buffer from NEB mini-prep kit and centrifuge 1 min at 16000 x g.

k. Add 700 μl Wash 2 buffer from NEB mini-prep kit and centrifuge 1 min at 16000 x g.

l. Add again 700 μl Wash 2 buffer from NEB mini-prep kit and centrifuge 1 min at 16000 x g.

m. Decant the supernatant and centrifuge 1 min at 16000 x g to dry the column.

n. Add 30 μl elution buffer from NEB mini-prep kit to elute the DNA and centrifuge 1 min at 16000 x g. Can divide into two days or continue same day from here.

26. The Illumina universal sequences are attached to the amplicon with an overlapping region included in the primers (Figure 3 ) using a first PCR.

Primers used for first PCR (corresponding to "Overlap sequence" on Figure 3 ):

Name Description Sequence Section of RBD amplification Steps Temperature Time Cycles

Step 1 37 °C 20 min 1

Step 2 80 °C 20 min 1 Hold 4 °C forever 28. Attach the barcodes and the Illumina adapter with a 2 nd PCR reaction. The barcode must be unique for each sample to allow the analysis of different samples on a single MiSeq run.

Primers used on 2nd PCR (corresponding to the Illumina primers -"Illumina adapter" and "Barcode"in Figure 3 ):

Illumina_FWD (RP1) aatgatacggcgaccaccgagatctacacgttcagagttctacagtccga

Note: nnnnnn refers to unique RPI Illumina barcode (full list: Illumina Adapter Sequences and Kowalsky et. al 2015) . In this study, we used adapters #1-20 but any set of adapters can be used. ii. Prepare a working solution by diluting the Quant-iT TM reagent 200-fold in TE.

The working solution must be prepared on the same day of the quantification and stay protected from the light, preferably wrapped in aluminum foil.

b. In a black 96-well plate (Product # 3792), prepare a 1:2 standard curve starting at 100ng/mL of Lambda DNA using the first row of the plate. Add 100 μL in each well and include a blank with 100 μL TE.

c. In the same plate, add 1 μL of purified sample in 99 μL TE.

Note: If the sample concentration is < 40 ng/μL, up to 2.5 μL of sample can be used. On the contrary, if the concentration is too high, necessary dilutions in IDTE can be carried out.

d. Add 100 μL Quant-iT TM working solution to each well and incubate for 5 min at 20-25°C while covered in foil.

e. Measure the fluorescence using a plate reader (ex: 480nm, em: 520 nm). Subtract the blank from all the samples and use the Lambda DNA serial dilutions to generate a standard curve of fluorescence vs DNA concentration. With the curve, determine the concentration of each sample. In our hands the concentrations are between 6 ng/μL and 60 ng/μL.

In a 1.5 mL tube, mix equivalent molar amounts of each sample to have the same number of reads and submit to a sequencing facility.

Libraries can be sequenced on an Illumina MiSeq using the MiSeq V2-500 cycle kit. While we have used the University of Colorado sequencing core, there are commercial and academic cores that offer sequencing as a fee-for-service (NovoGene or Rush University Medical Center, for example). The libraries have been split into two tiles assuming the use of 250 bp paired end sequencing, but our software supports longer paired-end reads as well. One critical detail essential for sequencing is dealing with the low nucleotide diversity of the RBD libraries. We circumvent this issue primarily by instructing the sequencing core to add PhiX in the pooled library, which is a crucial step for correct clustering of the sequences. PhiX is a well characterized adapter-ligated library that helps balance nucleotide diversity. We have obtained good sequencing results with 35% PhiX. Refer to Troubleshooting 4 if the DNA is not clustering correctly.

We typically obtain around 90% coverage for all the libraries screened.

This is the primary computational step in the protocol. This software package can perform all necessary analysis and interpretation of results. With the completion of this step, potential escape mutations are identified for a given antibody.

This software is divided into two separate modules. The first module manages the input FASTQ files and is abbreviated 'dms' for deep mutational scanning. The second module, titled 'analysis', is responsible for interpreting the output generated from the dms module. Apart from specifying which experiment to analyze before the analysis module is run, the transition between these two modules is seamless.

This protocol results in a total of three output files. The dms module generates one of these files and the analysis module identifies the other two. The output from the dms module is a comma-separated values (CSV) file that identifies the single mutations, their corresponding counts in each population, and an enrichment ratio (ER) that compares these counts. Next, the analysis module generates a CSV file with additional columns to the file generated in the dms module. The new columns identify the following for each observed mutation: the threshold ER value determined from the control data for a given tile, the p-value calculated by the one-sided exact Poisson rate ratio test, the FDR value, and the minimum number of nucleotides away the given mutation could be from the wild type sequence. The second output of the analysis module is a heatmap in Microsoft Excel that identifies potential escape mutations in blue. Refer to Figure 4 for details on the outputs mentioned above.

The dms module assumes that amplicons are of the same fixed length and that each amplicon is read in both the forward and reverse directions, leading to a pair of FASTQ files. When the module is run, it merges the paired reads of the FASTQ files, collapses identical synonymous mutations into single counts, and subsequently calculates enrichment ratios between specified populations (see 'Quantification and statistical analysis section'). A detailed explanation of this process has already been published (Fowler et al., 2011; Klesmith and Hackel, 2019) .

The analysis module performs the necessary analytical steps to identify the escape mutations. While a thorough explanation of the statistical approach is detailed in Quantification and statistical analysis, please refer to Figure 5 for an overview of the entire process.

33. Complete the configuration file to include the details of the experiment.

For the dms module, the user should fill out the configuration file to include all experiments. Therefore, the module can be run once and the analysis can be streamlined. An example configuration file is on Github. We recommend that this example file is copied and that the original document remains available for reference. For an explanation of each section and option in the configuration file, please refer to Table 2 and Table 3 . a. If the experiment of interest only uses one tile, refer to Troubleshooting 5.

The example configuration file is already filled out so that users only need to complete the file names, the file paths, and create names for their experiments. If the original libraries are used, no additional changes are needed to the configuration file. All other parameters and details are set as default and do not need to be changed for a successful run of the software.

34. Run the software by execution of commands at the command line. Some command line flags can be used here to override information set in the configuration file. Details about these command line arguments are in Table 4 .

a. Run the dms module. This module can be run with following command (assume the configuration file is titled example.config and that it is found in the root directory): python3 -m dms --config example.config

The dms module will deposit output files in a folder found in the root directory of the software unless the output directory is intentionally changed. The files are always deposited into the folder titled "Output". If that folder does not exist in the directory, an output folder will be created. Note: The dms package is a general deep mutational scanning tool. It can be run independently of any other analysis and does not depend on the other module described here.

b. Run the analysis module with the following command (again, assume the configuration file is titled example.config and that it is found in the root directory). The [Analysis] section of the configuration file must be updated before every run to represent accurate experiments. However, all other sections of the configuration file should remain the same for both modules: python3 -m analysis --config example.config i. Details on the approach for this analysis can be found in the Quantification and statistical analysis section.

The analysis module will deposit output files in a folder found in the root directory. The files are always deposited into the folder titled "Processed". If that folder does not exist in the directory, the folder will be created.

We provide the CSV outputs of the dms module on Github in the "Output" folder. There are two files: one representing the control population (example_control.csv), cells without ACE2 labeling, and the other representing an antibody population for CC12.1 (Francino-Urdaniz et al., 2021) , titled example_CC12.1.csv. In addition, the example configuration file provided is already configured to properly run the analysis module with these example files. The only required change is to update the file paths to the Output folder containing the aforementioned example files. To run the analysis module with this data, follow the instructions in step 34b.

The analysis module is written with the intention that it will be executed shortly after running the dms module. Therefore, if output files of the dms module are significantly edited, the analysis module may not run as expected.

There are several expected outcomes from the experimental procedure. These outcomes are included in the protocol, but they are also written here for completeness. First, in the preparation steps, cotransformation into yeast should result in >10 4 transformants for the wild type S RBD (Before you begin: #3e) and >1.2×10 5 transformants for each S RBD library (Steiner, Baumer and Whitehead, 2020) (Before you begin: #4j). Second, when making yeast stocks for the wild type S RBD (Before you begin: #3l), each 1.5 mL S. cerevisiae EBY100 culture will produce an average of six 1 mL yeast stocks. Third, the FACS step sorting 200,000 cells from the competing assay (Step-by-step method details: #18) should take around 40 min to collect if using our Sony SH-800 system. This time results from a sorting rate of 5-10,000 cells per sec and maintaining a 70% sorting efficiency. Finally, gel extraction in the sample preparation stage before sequencing (Step-by-step method details: #29) should always give one clear band with the correct size on the SYBR safe gel (515 bp for Tile 1 and 487bp for Tile 2). Any other expected outcomes during the experimental stages are very small and listed with their associated steps.

After the experimental work, the major outcome of the computational step is a statistical measure of how likely each single point mutant present in the library is of being an escape mutant for a specific neutralizing antibody. This information is captured in a comma-separated values (CSV) file generated by the analysis module. The most important information in this CSV file is a false discovery rate (FDR) for each mutation. The FDR for a mutation quantifies how many mutations we would expect to have similar, or more significant, enrichment ratios and depths of coverage by random chance. Other information contained in the CSV file for the set of mutants includes their corresponding counts in each population, an enrichment ratio (ER) that compares these counts, a p-value calculated by the one-sided exact Poisson rate ratio test, and the minimum number of nucleotides away the given mutation could be from the wild type sequence. The second output of this software is a heatmap in Microsoft Excel that identifies potential escape mutations in blue. Refer to Figure 4 for details on the outputs mentioned above.

All statistical analysis is performed by the custom software developed for this protocol. This occurs entirely in Step 3 from the procedures above. To determine escape mutations, the antibody population must be compared against the control group. A control was used to help identify which mutations are randomly expected to appear in the given library. With this data, we can determine the mutations present in the selected antibody population that occur more frequently than would typically be expected when looking at the control data. This information is captured as the FDR value. If these specific mutations have enough counts to be confident of their presence in the antibody library, then we call those variants escape mutations. A more detailed and formal explanation of the statistical approach follows.

First, the critical metric for determining escape mutants in this analysis is the enrichment ratio at each position. An enrichment ratio is the log2 transform of the frequency of an observed mutation in the selected population divided by the frequency of that mutation in the reference population ( Figure  6A ). This calculation is performed by the dms module prior to running any statistical analysis.

When running the analysis module, a kernel density estimate (KDE) is first fit to the control data. This provides an empirical ER distribution for cells sorted without antibody or ACE2 labeling, which serves as a null hypothesis in which observed ERs are due to stochasticity in sorting and other non-relevant differences between variants. In determining which distribution to use for this data, we initially fit common probability distributions ( Figure 6B) . However, KDE consistently provided a better fit to the data. In addition, a KDE eliminates the need to make the underlying assumptions common with parametric functions, yet still provides an accurate distribution (Kvam and Vidakovic, 2007) . Thus, given the unpredictable nature of the control data, a nonparametric probability distribution such as the KDE was chosen to ensure a reliable distribution for each given control group without making any assumptions about the distribution of data.

Using this KDE from the null distribution, a threshold value for enrichment ratios can be determined. We estimate the false discovery rate (FDR) for a given threshold as the number ERs we expect to find above that threshold in the null experiment. This is given by FDR = (1 − F(ER t )) * N, where F is the experimentally determined cumulative distribution function (CDF) of the control experiment ERs and N is the number of variants in the library. Rearranging, we find ER t = F −1 (1 − FDR N ), where F −1 is the inverse CDF. For a library size using these experiments (N = 1120 for tile 1 or N = 1260 for tile 2) and with an FDR = 1, the typical range for this threshold is 2.2 < ER t < 2.6.

We then compare each observed ER in an experiment to this threshold to see which variants have enrichment ratios larger than ER t . However, comparing just the observed ER to the threshold would ignore the depth of coverage for each mutation. Since the depth of coverage provides information about our confidence in the observed ER, we use it directly in the comparison. This is explained in detail below.

For a given experiment, we have two sets of reads {k i p } and two totals n p , where p ∈ {ref, sel} is the reference or selected population. Note that, since we discard reads that don't encode single mutations, it is not generally true that ∑ k i p i = n p . We approximate each read count k i p as being distributed as k i p~P ois(r i p n i p ) for some unknown rate r i p . If we knew this rate, the true enrichment ratio would be given by ER i = log 2 ( (Seabold and Perktold, 2010) . The significance level of the test, α, is determined by the user and can be changed in the configuration file. Our analysis used α = 0.01. Please refer to Figure 6C for additional details.

The method described has several experimental parts that introduce limitations to the protocol. First, this protocol identifies only the subset of neutralizing antibodies that directly compete with ACE2 for binding on S RBD. Neutralizing antibodies for SARS-CoV-2 can bind on Spike at locations other than the RBD (Cerutti et al., 2021; Mccallum et al., 2021; Li et al., 2021) , and some neutralizing antibodies recognize the N343 glycan that we have removed from the displayed S RBD to avoid hypermannosylation (Jigami, 2014) . A different approach taken by the Bloom research group can be considered if non-competing antibodies must be analyzed (Greaney et al., 2020; Starr et al., 2021) that also bind on the S RBD. We have previously tried to display the S ectodomain in yeast but were not successful (Francino-Urdaniz et al., 2021) .

Second, this procedure is only designed to identify escape mutants resulting from single amino acid mutations. The smaller single mutation library limits our ability to test the possibility that a combination of amino acid mutations could work in conjunction and ultimately lead to escaping antibody binding. Larger and more complex libraries would be needed to test this type of escape mutant. In addition, the custom software developed with this protocol is not written to identify such scenarios.

Third, the residues examined in this study are all located on the surface of S RBD. While ACE2 and other antibodies will only interact directly with these surface residues, it is possible that buried residues could have indirect impacts on binding. Furthermore, since we test monomeric S RBD some surface mutations identified as putative escapes by this method could produce steric clashes in the full trimeric S. Each mutation is pleiotropic with unpredictable potential changes in the fitness of the virus. Thus, the escape mutants identified by this protocol will necessarily be a subset of the escape mutants for these same positions observed in nature.

Finally, given that a mutation was observed in the population, the output is binary (yes/no for an escape mutant). Some true escape mutants may be missed if the mutation does not appear with high enough frequency in the antibody population. This is especially true if ER values are close to the cutoff, if the mutation is not sampled in the reference library, or if the control population has some aberrations that skew the ER threshold higher.

Increase PhiX percentage to increase nucleotide diversity to promote correct clustering.

Problem 5:

The example configuration file is not set up by default for running with only one tile. Thus, using the software for an experiment that only has a single tile may result in an error if the configuration file is not formatted correctly through the initial setup in Step-by-step method details step 33.

Potential solution:

To run a single tile, continue to add the experiment in the [Proteins] section. However, after identifying the first tile, add a comma and then a space (leaving the rest of the line blank). For example, if the experiment name is '6-29' and the chosen title for the protein is '1_6-29' then use the following format in the [Proteins] section.

This should fix any issues.

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Tim Whitehead timothy.whitehead@colorado.edu.

All plasmids and mutational libraries used in this work are available from AddGene (https://www.addgene.org/Timothy_Whitehead/).

All scripts used to process and analyze deep sequencing data are freely available on Github (https://github.com/WhiteheadGroup/SpikeRBDStabilization.git). 

This section combines different tiles that correspond to the same protein. This is so the information across all tiles for a given protein can be consolidated into single concise files.

The title for each protein is chosen by the user and should be entered without quotation marks. Each protein must be unique, and all proteins should be defined under this section.

The proteins must be defined as follows: protein_name: 'experiment_name1', 'experiment_name2', …, 'experiment_nameN'

'experiment_name1' -the name of the experiment that is the first tile for the protein 'experiment_name2' -the name of the experiment that is the second tile for the protein *All experiment_names must be defined in the [Experiments] section as options. The name of these samples must be compiled exactly into quotes in the [Proteins] section.

It is possible to define a protein with a single experiment, but the single quoted experiment name must be followed by a comma in the definition.

This section defines statistical parameters for the analysis module. The information provided here results in the final escape mutant hits identified.

Available options (described in Table 2 ): control_filepath, antibody_filepath, output_title, FDR, significance. The input must be a positive integer or None. If None, then no reads will be discarded due to mismatches.

The default value used in our analysis is 10.

The minimum sequencing quality score required to keep a read in the analysis. A read with a score lower than this minimum benchmark will be discarded.

The input must be a positive integer or None. If None, then no reads will be discarded due to quality.

The default value used in our analysis is 10.

Parameters fastq_file_dir This option allows the user to specify the directory that contains the FASTQ files to be analyzed. The file path should be a folder that contains FASTQ files with the file names provided in the configuration file. An absolute file path should be used.

The input must be a string.

An example for this value is: '/Users/lab/Documents/fastq_files' Tile:Tx wt_seq The nucleotide DNA sequence of the tile which includes the entire sequence of a read from deep sequencing. This generally includes the primers used.

The input must be a string of capital letters.

The default values used in our analysis is different for each Tile and shown below: Tile:Tx cds_start The nucleotide position in a merged read is where the coding sequence starts (after primers or any other miscellaneous nucleotides at the start of the read). Note: this index is given using Python slicing conventions, so it is zero-indexed. For example, the sequence 'GATC' is numbered 0123. If the sequence starts at 'A', cds_start would be 1.

The input must be a nonnegative integer.

The default used in our analysis is different for each Tile and shown below: Tile 1: 43 Tile 2: 18

Tile:Tx cds_end The nucleotide position in a merged read is where the coding sequence ends (before primers or any other miscellaneous nucleotides at the end of the read). Note: this index is given using Python slicing conventions, and so is the index of the first nucleotide that is not part of the coding sequence. For example, if the CDS is 'AT' in 'GATC', cds_end would be 3.

'/Users/lab/Documents/rbd/Output/example_CC12.1.csv'.

The prefix to be used in the processed file names at the end of running the analysis module.

An example of this value is: 'CC12-1'

The target false discovery rate (FDR) for identifying an enrichment ratio threshold. This threshold is then used to determine escape mutant hits.

The default used in our analysis is 1.

The p-value cutoff used to determine if a given enrichment ratio is significantly greater than the threshold value.

The default used in our analysis is 0.01.

This flag provides an option for the user to use the multiprocessing module or to turn it off. The multiprocessing module reads FASTQ files using multiple cores and can speed up the run time.

The default is set to True and the argument parser accepts yes, no, true, or false as options.

This flag allows the user to specify the directory that contains the FASTQ files to be analyzed. The file path should be a folder that contains FASTQ files with the file names provided in the configuration file.

The default is an empty string.

This flag allows the user to specify the output directory where all CSV and Microsoft Excel files will be saved when the run is complete.

The default is an empty string.

The maximum number of mismatches allowed when reading overlapping sequences of paired-end reads from FASTQ deep sequencing files. Reads with a higher number of mismatches are discarded.

The default is set to None which sets no limit to the number of mismatches and does not discard reads due to mismatches. Any other input should be a positive integer.

The minimum deep sequencing quality score required to keep a read in the analysis. A read with a score lower than this minimum benchmark will be discarded.

The default is set to None which sets no lower limit on the quality of a read and accepts all scores. Any alternative input must be a positive integer.

The cutoff used to discard variants that have a low number of counts in the reference population. Variants with reference counts below this cutoff will be discarded.

The default is set to 5 and inputs must be a nonnegative integer.

The pseudocount used when a variant contains counts observed in the reference population but not in the selected population. This is required because observing no counts in the selected population while having counts in the reference population will lead to an undefined enrichment ratio.

The default is set to 1 and inputs must be a positive integer.

S RBD does not display on the yeast surface or has a very low display. This problem may rise in Before you begin step 16 or Step-by-step method details step 12

Developed computational software: CMH, PJS

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite', Cell Host and Microbe

Isolating and engineering human antibodies using yeast surface display

Enrich: Software for analysis of protein function by enrichment and depletion of variants

One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Yeast Glycobiology and Its Application

Improved mutant function prediction via PACT: Protein Analysis and Classifier Toolkit

Nonparametric Statistics with Applications to Science and Engineering

High-resolution sequence-function mapping of full-length proteins

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2', Cell

Characterizing protein-protein interactions using deep sequencing coupled to yeast surface display

Statsmodels : Econometric and Statistical Modeling with Python

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016

A Method for User-defined Mutagenesis by Integrating Oligo Pool Synthesis Technology with Nicking Mutagenesis

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI141452 to T.A.W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by a Balsells Fellowship to I.M.F.U. and a CU Boulder BSI fellowship to C.M.H.

Low display percentages occur with insufficient culture aeration during growth. Ensure the 14 mL culture tube is shaking and that the culture volume is 1.5 mL or less. Induction time and temperature were optimized for our laboratory settings and may need to be altered to optimize display. Other common temperatures are 18°C and 30°C.If necessary, a 0.2 w/v% galactose can be added to the SDCAA + and 0.2 w/v% dextrose can be added to the SGCAA + . If the RBD is still not displaying, co-transform again.

No or low PE signal increase when binding biotinylated ACE2 to the displayed RBD. This problem may arise in Before you begin step 22 or Step-by-step method details step 13 Tube 2.

Increase the biotin to protein ratio. If the signal increases as the ratio increases, use the necessary ratio to see a good PE signal increase.

Product from the second PCR when preparing the libraries for deep sequencing does not show on a SYBR safe gel in Step-by-step method details step 29.

First check that there is some product on the right band size using the more sensitive SYBR gold stain. If so, rerun the PCR steps using more cycles. Else, cells could have been contaminated during cell recovery or the yeast miniprep did not have a high enough yield.

Author contributions J o u r n a l P r e -p r o o f

The authors declare no competing interests.

This section defines the basic parameters for the dms module.Available options (described in Table 2 ): max_mismatches, min_quality, and fastq_file_dir.Tile:Tx This section defines a tile that will be analyzed. For every tile in an experiment, a new tile section should be created. To define a tile, change the name after the colon.Available options (described in Table 2 ): wt_seq, first_aa, cds_start, cds_end, and positions.Note: this section should generally remain unchanged from the example configuration file. The option to change these parameters is provided as a convenience for anyone following these protocols with different libraries.

This section defines the different samples in the experiment, connecting the tiles with the file names for the paired-end reads. All samples are in this section, no other [Samples] section is necessary to define multiple samples.The title for each sample is chosen by the user and should be entered without quotation marks. Each sample must be unique, and all samples should be options under [Samples] .The samples must be defined as follows: sample_name: 'Tx', 'FASTQ_filename1', 'FASTQ_filename2''Tx' -the tile identifier that must match the tile name provided in the tile section.'FASTQ_filename1' -the name of the FASTQ file that contains the sample's forward reads. The input must be a list of integers. For example: [22, 42, 44, 51] . If you desire only one residue, enter the integer as a list (e.g.[31]).The default positions used in our analysis is different for each Tile and shown below: Tile 1: 333, 334, 335, 339, 340, 344, 345, 346, 349, 351, 352, 354, 356, 357, 358, 359, 360, 362, 363, 364, 366, 367, 370, 372, 373, 375, 376, 377, 378, 380, 381, 382, 383, 384, 385, 386, 388, 389, 390, 394, 396, 405, 408, 411, 412, 413, 414, 415, 417, 420, 421, 424, 426, 427, 428, 430 Tile 2: 437, 439, 440, 441, 444, 445, 446, 447, 448, 449, 450, 452, 455, 456, 457, 458, 459, 460, 462, 463, 464, 465, 466, 468, 469, 470, 471, 473, 474, 475, 477, 478, 479, 481, 482, 483, 484, 485, 486, 487, 489, 490, 492, 493, 494, 498, 499, 500, 501, 503, 504, 505, 506, 508, 516, 517, 518, 519, 520, 521, 522, 523, 527 Analysis control_filepath The file path, including the file name, to the output file from the initial deep mutational scanning module for the control experiment. Absolute file paths should be used.Include extensions, if applicable.An example of this value is: '/Users/lab/Documents/rbd/Output/example_control.csv'.

The file path, including the file name, to the output from the initial deep mutational scanning module for the desired antibody experiment. Absolute file paths should be used.Include extensions, if applicable.An example of this value is: